Announcements
16 November 2023
Cancers | Highly Cited Special Issues on Infectious Agents and Cancer in 2022
We are pleased to invite you to read the highly cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on the topic of infectious agents and cancer.
The Special Issues list is as follows:
 “Molecular Pathogenesis of Epstein-Barr Virus-Associated Malignancy”Edited by Prof. Dr. Hironori Yoshiyama, Prof. Dr. Asuka Nanbo and Prof. Dr. Tomoharu Yasuda Views: 12600+ | Cited by 11+ |
|
|
|
|
“
“
“You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers via cancers@mdpi.com.
Cancers Editorial Office
16 November 2023
Cancers | Highly Cited Special Issues on Cancer Therapy in 2022
We are pleased to invite you to read the highly cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on cancer therapy. We hope this announcement will provide useful information for this field.
The Special Issues list is as follows:
|
|
|
|
“Advances in Lung Cancer Therapy” |
“Application of Proton Beam Therapy in Cancer Treatment” |
|
|
|
|
“Drug Repurposing for Cancer Therapy” |
“Novel Targets and Approaches in Cancer Therapy” |
|
|
|
|
“New Strategies in Diagnosis and Treatments for Brain Tumors” |
“Radiation Therapy in Thoracic Tumors: Recent Trends and Current Issues” |
You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.
Cancers Editorial Office
16 November 2023
Cancers | Highly Cited Special Issues on Cancer Metastasis in 2022
We are pleased to invite you to read the highly cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on cancer metastasis. We hope this announcement will provide useful information for this field.
The Special Issues list is as follows:
|
|
|
|
“From Progression to Metastasis of Solid Cancer” |
“Brain Metastasis in Breast Cancer” |
|
|
|
|
“Understanding Molecular Regulation of Cancer Progression and Metastasis” |
“Colorectal Cancer Heterogeneity and the Impact on Metastasis Formation and Therapy Efficacy” |
|
|
|
|
“Metastasis and Tumor Cell Migration of Solid Tumors” |
“Genomic Landscape of Breast Cancer: From Primary to Metastasis” |
You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office at cancers@mdpi.com.
Cancers Editorial Office
15 November 2023
Cancers | Highly Cited Special Issues on Methods and Technologies Development in 2022
We are pleased to invite you to read the highly cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on the topic of methods and technologies development.
The Special Issues list is as follows:
|
|
|
|
“Novel Techniques and Technology for Treatment of Brain Tumors” |
“Biophotonics and Imaging for Cancer Screening, Diagnosis and Treatment Monitoring” |
|
|
|
|
“Recent Advances in Nanotechnologies for Cancer Detection and Treatment” |
“Non-Invasive Imaging and Spectroscopic Methods in Cancer” |
|
|
|
|
“Application of Emerging Technologies in Zebrafish and Mammalian Cancer Models for Disease Characterization and Therapeutic Target Discovery” |
“Current Advances in Chimeric Antigen Receptor Technology” |
You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.
Cancers Editorial Office
15 November 2023
Cancers | Highly Cited Special Issues on Molecular Cancer Biology in 2022
We are pleased to invite you to read the highly cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on molecular cancer biology. We hope this announcement will provide useful information for this field.
The Special Issues list is as follows:
|
|
|
|
“Updates on Molecular Targeted Therapies for CNS Tumors” |
“Molecular Genetics and Treatment of Chronic Myeloid Leukemia” |
|
|
|
|
“Molecular Mechanisms Underlying Tumor Onset and Progression in Liver Cancers” |
“Molecular Pathogenesis and Management of Anaplastic Large Cell Lymphoma” |
|
|
|
|
“Molecular Mechanisms of Lung Cancer and Mesothelioma” |
“Molecular Pathogenesis of Cervical Cancer” |
You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers.
Cancers Editorial Office
15 November 2023
Cancers | Highly Cited Special Issues on Cancer Immunology and Immunotherapy in 2022
We are pleased to invite you to read the highly cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on cancer immunology and immunotherapy. We hope this announcement will provide useful information for this field.
The Special Issues list is as follows:
|
|
|
|
“Tumor Immunology and Immunotherapy Resistance” |
“Perspectives of Immunotherapy in Tumors of the Gastrointestinal Tract” |
|
|
|
|
“Immunotherapy of Triple-Negative Breast Cancer” |
“Cancer Immunotherapy and Immune-Related Adverse Events” |
|
|
|
|
“Oncolytic Viruses as Cancer Immunotherapy Agents” |
“Immunotherapy for Solid Tumors” |
You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.
Cancers Editorial Office
14 November 2023
Cancers | Highly Cited Special Issues on Clinical Research of Cancer in 2022
We are pleased to invite you to read the highly cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on clinical research of cancer. We hope this announcement will provide useful information for this field.
The Special Issues list is as follows:
|
|
|
|
“Clinical Perspective and Translational Oncology of Liquid Biopsy” |
“Immune Checkpoint Inhibitors in Cancer Therapy—How Can We Improve Clinical Benefits?” |
|
|
|
|
“Clinical Use of PARP Inhibitors in Cancer – From Bench to Bedside and Back Again” |
“Clinical, Pathological, and Molecular Characteristics in Colorectal Cancer” |
|
|
|
|
“Latest Basic, Translational and Clinical Advancements in HER2-Positive Breast Cancer” |
“Ewing Sarcoma: Basic Biology, Clinical Challenges and Future Perspectives” |
You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.
Cancers Editorial Office
13 November 2023
Cancers | Highly Cited Special Issues on Cancer Drug Development in 2022
We are pleased to invite you to read the highly cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on cancer drug development. We hope this announcement will provide useful information for this field.
The Special Issues list is as follows:
 |
 |
| “New Diagnostic and Therapeutic Tools Against Multidrug Resistant Tumors” Edited by Prof. Dr. Chiara Riganti, Dr. M. Helena Vasconcelos and Prof. Dr. Catherine Passirani Viewed by 38700+ | Cited by 160+ |
“Tumor Models and Drug Targeting In Vitro” Edited by Dr. Sascha Kopp and Dr. Marcus Krüger Viewed by 18700+ | Cited by 30+ |
 |
 |
| “The Roles of microRNAs in Cancer Aggressiveness and Drug Resistance” Edited by Dr. Bi-Dar Wang and Prof. Dr. Luciane R Cavalli Viewed by 20900+ | Cited by 80+ |
“Cancer Stem Cells (CSCs) in Drug Resistance and Their Therapeutic Implications in Cancer Treatment” Edited by Dr. Peter Van Veldhuizen Viewed by 18000+ | Cited by 50+ |
 |
 |
| “Recent Advances in Drug Therapy for Glioblastoma” Edited by Dr. Juan Manuel Sepúlveda-Sánchez Viewed by 17000+ | Cited by 30+ |
“microRNA and Oxidative Drugs in Cancer Therapy and Prevention” Edited by Prof. Dr. Alberto Izzotti and Prof. Dr. Ming You Viewed by 17300+ | Cited by 30+ |
You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.
Cancers Editorial Office
10 November 2023
Cancers | Highly Cited Special Issues on Cancer Survivorship and Quality of Life in 2022
We are pleased to invite you to read the Highly Cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on Cancer Survivorship and Quality of Life. We hope this announcement will provide useful information for this field.
The Special Issues list is as follows:
|
|
|
|
“The Role of Lifestyle-Related Factors in Cancer Survivorship” |
“Lymphoma Survivorship” |
|
|
|
|
“New Sights in Cancer Survival Analysis: Non-clinical Determinants of Survival for Patients with Cancer” |
“Lifestyle Modifications and Survival of Cancer Patients” |
|
|
|
|
“Palliative and Supportive Care in Oncology: An Update” |
“Physical Activity and Cancer Care” |
You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers.
https://www.mdpi.com/journal/cancers/special_issues.
Cancers Editorial Office
10 November 2023
Cancers | Highly Cited Special Issues on Cancer Causes, Screening and Diagnosis in 2022
We are pleased to invite you to read the Highly Cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on Cancer Causes, Screening and Diagnosis. We hope this announcement will provide useful information for this field.
The Special Issues list is as follows:
|
|
|
| “Cervical Cancer Screening and Treatment in the 21st Century” by Dr. Alina E. Sturdza Views: 13600 + | Citations: 25+ |
“Artificial Intelligence and Advanced Medical Imaging in Cancer Diagnosis and Precision Care” |
|
|
|
| “Uveal Melanoma: From Diagnosis to Therapy” by Dr. Emine Kilic Views: 30400 + | Citations: 65+ |
“Bio-Pathological Markers for the Diagnosis and Therapy of Cancers, Volume II” by Dr. Lucia Salvatorelli and Dr. Giuseppe Broggi Views: 13700 + | Citations: 35+ |
|
|
|
|
“Cancer Genomics: Interpreting the Changing Landscape in Cancer Diagnosis and Treatment” |
“Recent Developments of Nuclear Medicine in Cancer Diagnosis and Theranostics” |
You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers.
https://www.mdpi.com/journal/cancers/special_issues.
Cancers Editorial Office
